Logo

    #269 - Good vs. bad science: how to read and understand scientific studies

    enSeptember 04, 2023
    What was the main topic of the podcast episode?
    Summarise the key points discussed in the episode?
    Were there any notable quotes or insights from the speakers?
    Which popular books were mentioned in this episode?
    Were there any points particularly controversial or thought-provoking discussed in the episode?
    Were any current events or trending topics addressed in the episode?

    Podcast Summary

    • The importance of critical thinking and understanding the research process in comprehending scientific studies.Developing critical thinking skills and understanding the research process allows individuals without scientific backgrounds to accurately interpret and understand scientific studies.

      Understanding scientific studies requires a clear understanding of the research process and critical thinking skills. The process of conducting a study involves formulating a hypothesis, creating a design, and executing the study. Good science is hypothesis-driven and involves testing the null hypothesis, which assumes no relationship between phenomena. It is essential to distinguish between the null and alternative hypothesis to interpret study findings accurately. Additionally, readers must be aware of the limitations and strengths of different types of studies and ask relevant questions to assess their rigor. In today's age of contradictory findings, it is crucial to approach research with skepticism and evaluate the quality of evidence presented in news or publications. Developing these skills will enable individuals with no scientific background to better understand and interpret scientific studies.

    • Steps in Conducting an Experimental StudyConducting an experimental study involves formulating hypotheses, designing the experiment, determining variables, obtaining approvals, defining outcomes, developing a statistical plan, and securing funding.

      Conducting an experimental study involves several important steps. Firstly, formulating a null hypothesis and an alternative hypothesis is crucial. Secondly, designing the experiment, including determining variables such as duration and frequency of coffee consumption and deciding on the measurement of eye color. Additionally, determining the number of subjects and conducting a power analysis are necessary. It is also essential to obtain institutional review board approval if the study involves human or animal subjects. Other steps include defining primary and secondary outcomes, getting protocol approval, developing a statistical plan, and pre-registering the study. Lastly, securing funding is crucial. There are different types of studies, such as observational studies, experimental studies, and summations or analysis of studies.

    • Different Types of Studies in Research and HealthcareDifferent types of studies, from individual case reports to randomized controlled trials, offer valuable insights into medical conditions and treatment options, each contributing to our understanding in their own unique ways.

      Different types of studies serve different purposes in the field of research and healthcare. Individual case reports are valuable for generating hypotheses and highlighting interesting observations, although they may not be generalizable to a larger population. Case series expand on this by examining multiple patients with similar findings and can provide more evidence for hypothesis generation. Cohort studies, whether retrospective or prospective, offer a larger sample size and focus on observing patterns and associations, but do not involve any interventions. Finally, experimental studies, particularly randomized controlled trials, are considered the gold standard for research as they aim to minimize bias by randomly assigning participants to different treatment groups. Each type of study contributes to our understanding of medical conditions and treatment options in their own unique ways.

    • The importance of scrutinizing individual studies within a meta analysisWhile meta analysis can be a powerful tool, it is crucial to evaluate the quality and rigor of the individual studies included in it to determine the reliability of its findings.

      Meta analysis can be a powerful tool in combining data from multiple studies to examine the same question. However, it is important to not blindly trust a meta analysis without scrutinizing each individual study that it includes. The quality and rigor of the constituent studies are crucial in determining the reliability of the meta analysis. Even though meta analysis is often considered the top of the pyramid in terms of evidence, a single well-designed and rigorous randomized controlled trial can still hold more weight and reliability than a poorly constructed meta analysis. Therefore, it is essential to thoroughly evaluate the individual studies within a meta analysis to ensure the validity of its findings. Additionally, the conversation briefly mentions the different phases of clinical trials, with phase 3 trials typically being the final stage before a treatment is approved for use.

    • Phases of drug testing in humansDrug testing in humans involves several phases, starting with safety and tolerability evaluation in phase 1 and progressing to rigorous assessments of both safety and efficacy in phase 3.

      The process of testing new drugs in humans involves several phases, starting with an investigational new drug application (IND) filed with the FDA. Phase 1 focuses on dose escalation and determines the safety and tolerability of the drug in a small group of patients. Phase 2 aims to evaluate safety further and looks for initial signs of efficacy in an open-label fashion. Sometimes, comparisons to the natural history of the disease are made. If the drug successfully passes phase 2, it moves on to phase 3, which is a rigorous trial that thoroughly assesses both safety and efficacy. It is crucial to have both safety and efficacy demonstrated before proceeding to the next phase of testing.

    • The Importance of Large-Scale Clinical Trials in Determining Drug Effectiveness and SafetyRigorous clinical trials are essential for making informed healthcare decisions, as they provide reliable results on the effectiveness and safety of new drugs, unlike observational studies with limitations.

      Conducting large-scale clinical trials, known as phase 3 and post-marketing studies, is crucial to determine the effectiveness and safety of new drugs. These studies involve thousands of patients and often compare standard of care treatment with a new agent. They are conducted in a randomized and blinded manner to ensure reliable results. Phase 4 studies are conducted after drug approval to gather additional information on the drug's efficacy and potential side effects, as well as explore new indications for its use. Observational studies, on the other hand, have limitations due to factors like selection bias and healthy user bias, making it challenging to draw definitive conclusions. Therefore, it is important to rely on rigorous clinical trials to make informed healthcare decisions.

    • Limitations and Flaws of Nutritional EpidemiologyNutritional epidemiology is hindered by recall bias and unreliable data, making it important to approach studies in this field with caution and skepticism.

      Nutritional epidemiology, particularly when it comes to recall bias and food frequency questionnaires, is highly flawed. The reliance on people's ability to accurately recall and report their food consumption over extended periods of time leads to unreliable data. The limitations of this method become even more apparent when compared to the advanced tools and technologies used in other scientific fields. The lack of frequency and specificity in these questionnaires further compounds the problem and hinders the accurate assessment of dietary habits. Therefore, it is crucial to approach studies and findings based on nutritional epidemiology with caution and skepticism, as they may not provide a truly accurate representation of the relationship between diet and health.

    • The limitations of food frequency questionnaires and the influence of observation on behavior in research studies.Food frequency questionnaires may not accurately reflect dietary habits and researchers should consider the potential impact of observation on behavior when designing studies.

      Food frequency questionnaires should be abandoned in research studies. Peter Attia argues that recall is only reliable for profound events like childbirth, not for general dietary habits. Additionally, he questions the validity of inferring causality from recall data due to other factors at play. He criticizes the overemphasis on epidemiology in research, suggesting that its value has been overstated. The conversation also highlights the Hawthorne effect, which states that behavior changes when someone is being observed. This phenomenon can affect study outcomes, particularly in open label trials where competitiveness and performance can be influenced by awareness of observation. Furthermore, the discussion mentions the impact of having someone watch your eating habits, whether physically or virtually. Overall, the accuracy of recall data and the influence of observation on behavior are important considerations in research design.

    • The impact of performance bias and multiple hypothesis testing on clinical trial results.Performance bias and multiple hypothesis testing can lead to misleading results in clinical trials, emphasizing the importance of minimizing these biases for accurate findings.

      Performance bias and multiple hypothesis testing can significantly impact the results of clinical trials. In the example given, the group following the potato diet achieved better weight loss outcomes compared to the calorie restricted group. However, this difference can be attributed to the fact that the potato diet group received more attention, coaching, and positive behavioral influence. Such performance bias can create misleading results in randomized controlled trials, particularly in lifestyle-based studies. Additionally, multiple hypothesis testing can lead to false positives when researchers analyze the data from different angles or conduct multiple tests. It is crucial for researchers to be aware of these biases and design trials that minimize them to ensure accurate and reliable findings.

    • Considerations in Data Analysis: Bonferroni Correction, Confounding Variables, and Randomization in Experimental StudiesWhen analyzing data, remember to apply the Bonferroni correction to account for multiple looks at the data, address confounding variables in observational studies, and ensure rigorous randomization in experimental studies for accurate results.

      When analyzing data, it is important to consider the Bonferroni correction factor to account for multiple looks at the data. This correction factor requires dividing the p value by the number of times the data has been examined, raising the bar for what is considered statistically significant. Additionally, confounding variables, such as age, sex, and smoking, must be addressed in observational studies to mimic the randomization of experiments. However, it is nearly impossible to identify and eliminate all confounders. When evaluating experimental studies, randomization is crucial, and it should be done rigorously to ensure accurate results. A famous example, the Predimed study, was reanalyzed and raised concerns about improper randomization, highlighting the importance of critically examining studies to understand the full story.

    • Understanding the Challenges of Randomized Controlled TrialsProper randomization, differentiation between true randomization and cluster randomization, and careful planning and analysis are essential for accurate and reliable results in randomized controlled trials.

      Designing and conducting randomized controlled trials (RCTs) can be challenging, especially when it comes to the randomization process and control groups. The conversation highlights the importance of differentiating between true randomization and cluster randomization, as well as the need for different statistical adjustments in each case. It also emphasizes the difficulties in implementing a crossover design, where participants serve as their own controls. While this design reduces the number of subjects required and can be cost-effective, it poses challenges in terms of treatment order and potential lingering effects. Ultimately, the discussion underscores the complexity of RCTs and the importance of careful planning and analysis to ensure accurate and reliable results.

    • Factors to Consider in Scientific Studies and Clinical TrialsWhen conducting studies and trials, consider the order of treatments, the importance of blinding, the impact of study population heterogeneity, the clinical significance of outcomes, and potential conflicts of interest.

      When conducting scientific studies and clinical trials, it is crucial to consider several factors. First, the order in which treatments are given can have an impact on the results, with the suggestion being that going from treatment A to B and then from B to A is more effective. Secondly, blinding, whether single or double, is essential to minimize biases and ensure unbiased results. However, blinding can pose challenges, especially in studies involving psychedelics. Furthermore, the study population's heterogeneity affects the generalizability of the findings, and larger studies conducted across multiple sites can bring in more diversity but also introduce potential biases from rogue sites. Additionally, the clinical significance of study outcomes should be taken into account, not just statistical significance. Finally, researchers should be aware of funding sources and potential conflicts of interest that may impact the trial's transparency and reliability.

    • Understanding statistical power and interpreting p values for research findings.Balancing the significance threshold to minimize false positives and false negatives is crucial in statistical analysis, ensuring accurate interpretation of research findings.

      Understanding statistical power and interpreting p values are crucial in interpreting research findings. Power, defined as 1 minus beta, refers to the probability of correctly detecting a true effect or avoiding a false negative. On the other hand, a false positive is represented by the p value (alpha), which indicates the likelihood of observing an effect by chance. It is important to aim for low p values, preferably less than 0.05, to increase confidence in rejecting the null hypothesis. However, setting the p value threshold too low can lead to the risk of discarding relevant information and encountering false negatives. Achieving a balance between minimizing false positives and false negatives is essential in statistical analysis.

    • Understanding Power in Clinical TrialsPower is the ability of a study to detect a true effect. By analyzing a power table, researchers can determine the sample size needed for statistically significant results, avoiding underpowering or overpowered studies. Consider power to ensure valid and relevant findings.

      Understanding power is crucial when designing any kind of clinical trial or experiment. Power refers to the ability of a study to detect a true effect if it exists. It is determined by factors such as the sample size and the expected difference between treatment groups. By analyzing a power table, researchers can determine the number of subjects needed for their study to be statistically significant at a certain level. It is crucial to avoid underpowering a study, where there are not enough participants to detect a true effect, as well as overpowered studies, which may find statistically significant but clinically irrelevant results. By appropriately considering power, researchers can ensure the validity and relevance of their findings.

    • The importance of power in experimental studies and the significance of considering both relative and absolute risk in interpreting study findings.Adequate power in a study is crucial for detecting differences between groups, and understanding both relative and absolute risk is essential for fully understanding the implications of a study.

      Power in experimental studies is crucial and often overlooked. When evaluating a study, it is important to consider if it was adequately powered to detect a difference between the groups being studied. This information is usually found in the study's power analysis or protocol. Understanding the effect size being looked for and the number of participants needed helps determine the reliability of the study's findings. Additionally, researchers often report relative risk without providing absolute risk, which can be misleading. Knowing both the relative and absolute risk is critical in fully understanding the implications of a study. As seen in the example of hormone replacement therapy and breast cancer, the relative risk increase was reported as 25%, but the absolute risk increase was only 1 case per 1000 women, highlighting the importance of considering both measures.

    • Understanding Hazard Ratios and Absolute Risk Reduction in Clinical TrialsUnderstanding hazard ratios and absolute risk reduction is important for analyzing clinical trials and making informed decisions about the effectiveness, side effects, and costs of treatments.

      Understanding hazard ratios and absolute risk reduction is crucial in analyzing clinical trials and making informed decisions. Hazard ratios, calculated using complex math, measure the association between two groups over time. They provide valuable insights into the risk of disease progression or benefits of a treatment. Meanwhile, absolute risk reduction focuses on the actual decrease in events and is essential in determining the number needed to treat (NNT) to achieve a desired outcome. By dividing 1 by the absolute risk reduction, we can determine how many individuals need to receive the treatment to prevent the event. This knowledge is vital as it allows us to evaluate the effectiveness, side effects, and costs of treatments, ensuring informed decision-making.

    • Evaluating Drug Effectiveness: The Number Needed to Treat (NNT) and Confidence IntervalsNNT measures the impact of a drug, with a lower number indicating a more significant effect. Confidence intervals provide insight into study results, helping healthcare professionals make informed treatment decisions.

      The Number Needed to Treat (NNT) is a valuable measure when evaluating the effectiveness of a drug or treatment. A lower NNT indicates a more significant impact. For example, if a drug reduces the risk of death from 4% to 2%, the NNT would be 50, which is impressively low. On the other hand, if the reduction is from 4% to 1%, the NNT would be 33, indicating an even more substantial effect. Additionally, confidence intervals play a crucial role in interpreting study results. A wider interval suggests greater uncertainty, while a narrower interval suggests more confidence in the findings. When the confidence interval includes the value of 1, the results are not considered significant. Understanding NNT and confidence intervals helps healthcare professionals make informed decisions about treatments and interventions.

    • Understanding confidence intervals and the importance of critical thinking in interpreting scientific information.When interpreting studies, consider the confidence intervals to evaluate reliability. Don't rely solely on media for science information; critical thinking and understanding statistical concepts are crucial. Studies may be stopped for various reasons.

      When interpreting studies and scientific information, it is important to understand the concept of confidence intervals and uncertainty. A wider confidence interval indicates greater uncertainty, while a narrower interval indicates more confidence in the results. It is crucial to carefully analyze and consider the confidence intervals presented in studies to evaluate the reliability of the findings. Additionally, when reading scientific papers, it is important to be diligent, pay attention to details, and continuously educate oneself. Science requires critical thinking and the ability to understand statistical concepts. Therefore, relying solely on media or social media platforms for science information may not provide accurate or comprehensive understanding. Finally, studies may be stopped midway due to safety concerns, significant benefits observed, or futility in obtaining meaningful results.

    • Importance of Prioritizing Patient Safety in Clinical TrialsPatient safety should always be the top priority in clinical trials, even if it means stopping the study early.

      Sometimes clinical trials need to be stopped early for safety reasons. This was exemplified by the case of the CTAP inhibitor study, where the trial was set up to compare the combination of the inhibitor with Lipitor to Lipitor alone. The trial intended to follow patients for almost five years, but a monitoring board discovered that a higher number of patients receiving the drug combination had died compared to those on Lipitor alone. This prompted the board to advise Pfizer to halt the trial, which they did. It's important to note that even though the trial was stopped early, a published paper was still produced, reporting the endpoints at the time of study termination. This example demonstrates the significance of prioritizing patient safety in clinical research.

    • Importance of rigorous evaluation and research in pharmaceutical development and drug trials.Thorough research, analysis, and rigorous evaluation are crucial in pharmaceutical development to ensure effectiveness, safety, and credibility of drugs before market release.

      Pharmaceutical companies need to carefully evaluate the effectiveness and safety of their drugs before proceeding with trials and releasing them to the market. The example of CTP inhibitors and the different outcomes observed in previous trials highlight the importance of thorough research and analysis. Even small changes in drug molecules can significantly impact their efficacy and potential side effects. Additionally, the discussion on the Look ahead trial emphasizes the need for futility analysis to determine whether further study is warranted. The process of getting a paper published in a journal also requires rigorous peer review to ensure the quality and credibility of the research. Transparency and consideration of conflicts of interest are vital in this process.

    • Overcoming Publication Bias Through PreregistrationPreregistration of experiments can help mitigate publication bias by ensuring that all studies, regardless of their results, are published, thus promoting unbiased decision-making and advancing scientific knowledge.

      Publication bias poses a significant problem in the scientific community. Many studies, even if they are negative or do not yield the desired results, do not get published. This leads to a lack of comprehensive knowledge and hinders scientific progress. It is crucial to overcome publication bias by implementing strategies such as preregistration. Preregistration requires investigators to register their experiments, including statistical methods, number of subjects, and primary and secondary outcomes, before conducting the study. By making preregistration a prerequisite for publication in scientific journals, it becomes more difficult to selectively publish only positive or favorable results. This helps prevent the distortion of scientific knowledge and supports unbiased decision-making in future research endeavors.

    • The benefits of registered reports in combating publication bias and improving research quality.Registered reports enhance scientific rigor by promoting the publication of negative or neutral results, encouraging peer review of study design, and considering the impact factor when evaluating journal reputation.

      Registered reports are a valuable tool for combating publication bias and ensuring the establishment of knowledge based on rigorous research. With registered reports, researchers submit their protocols for peer review before data collection, and if the protocol is deemed high quality and everything looks good, the study is provisionally accepted for publication. This eliminates the bias towards positive findings and encourages the publication of negative or neutral results that are equally important for the advancement of knowledge. Additionally, registered reports provide an opportunity for peers to identify flaws in study design, such as underpowered experiments, and offer suggestions for improvement. The conversation also highlights the importance of considering the impact factor when evaluating the reputation of journals, with higher impact factors indicating greater citation and recognition within the scientific community.

    • Evaluating the Clinical Significance of Scientific Journals and the Role of OutliersEvaluating scientific papers involves assessing the abstract, study design, results, and discussion sections. Mentorship emphasizes early creation of figures and tables in the research process.

      The impact factor and number of citations of scientific journals can indicate their clinical significance. Journals like the New England Journal of Medicine, Lancet, and JAMA are considered highly influential because of their high impact factors and large number of citations. However, there are outliers like the cancer journal for clinicians, which has a high impact factor despite fewer citations due to its focus on cancer statistics. The process of reading a scientific paper involves first evaluating the abstract to determine interest, then delving into the methods section for details on the study design. Figures and tables in the results section should be stand-alone and easily understandable. Lastly, the discussion section provides additional insights and allows for comparing one's own thoughts with the authors'. Mentorship, as exemplified by Steve Rosenberg's approach, emphasizes the importance of creating figures and tables early in the research process.

    • Mastering Figures and Tables: The Key to Writing a Successful PaperUnderstanding and effectively presenting relevant figures and tables is essential for a successful paper. Providing valuable content and engaging with members through premium benefits helps create a supportive community. Medical advice should be sought from professionals.

      Peter Attia believes that understanding the relevant figures and tables and being able to explain them concisely in a legend is crucial for writing a successful paper. He suggests that once you have this foundation, the rest of the paper comes together easily, with the methods and results sections being straightforward to write. Attia also emphasizes the importance of providing valuable content without relying on paid ads and instead relying on member subscriptions for support. By offering premium membership benefits such as comprehensive show notes, AMA episodes, a premium newsletter, and access to a private podcast feed, he aims to provide members with more value than the cost of the subscription. Additionally, Attia acknowledges that the information shared on his podcast is for informational purposes only and not a substitute for professional medical advice.

    Recent Episodes from The Peter Attia Drive

    Improve your decision-making, frameworks for learning, backcasting, and more | Annie Duke (#60 rebroadcast)

    Improve your decision-making, frameworks for learning, backcasting, and more | Annie Duke (#60 rebroadcast)

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    In this episode, former World Series of Poker champion and author Annie Duke explains how poker is a pertinent model system for decision-making in the real world, a system which blends imperfect information with some unknown percentage of both luck and skill. Annie breaks down the decision-making matrix, revealing how we often focus too narrowly on just one of the four quadrants, missing out on valuable learning opportunities in the remaining 75% of situations. She delves into how our tendency to evaluate only negative outcomes leads to a culture of risk aversion. This mindset, she argues, stifles the kind of bold decision-making necessary for progress and innovation across various fields, from poker and sports to business and medicine. Annie also introduces a robust framework for learning and the levels of thought required to excel in any domain. Finally, she discusses a strategy called “backcasting”, a concept that resonated deeply with Peter in terms of how he thinks about extending healthspan.

    We discuss:

    • Annie’s background, favorite sports teams, and Peter’s affinity for Bill Belichick [1:30];
    • Chess vs. poker: Which is a better metaphor for decision-making in life (and medicine)? [6:45];
    • Thinking probabilistically: Why we aren’t wired that way, and how you can improve it for better decision-making [12:30];
    • Variable reinforcement: The psychological draw of poker that keeps people playing [19:15];
    • The role of luck and skill in poker (and other sports), and the difference between looking at the short run vs. long run [32:15];
    • A brief explanation of Texas hold ‘em [41:00];
    • The added complexity of reading the behavior of others players in poker [47:30];
    • Why Annie likes to “quit fast,” and why poker is still popular despite the power of loss aversion [52:45];
    • Limit vs. no-limit poker, and how the game has changed with growing popularity [55:15];
    • The advent of analytics to poker, and why Annie would get crushed against today’s professionals [1:04:45];
    • The decision matrix, and the “resulting” heuristic: The simplifier we use to judge the quality of decisions —The Pete Carroll Superbowl play call example [1:10:30];
    • The personal and societal consequences of avoiding bad outcomes [1:21:45];
    • Poker as a model system for life [1:31:30];
    • How many leaders are making (and encouraging) status-quo decisions, and how Bill Belichick’s decision-making changed after winning two Super Bowls [1:35:15];
    • What did we learn about decision-making from the Y2K nothingburger? And how about the D-Day invasion? [1:39:30];
    • The first step to becoming a good decision maker [1:43:00];
    • The difference between elite poker players and the ones who make much slower progress [1:49:45];
    • Framework for learning a skill, the four levels of thought, and why we hate digging into our victories to see what happened [1:52:15];
    • The capacity for self-deception, and when it is MOST important to apply four-level thinking [2:00:30];
    • Soft landings: The challenge of high-level thinking where there is subtle feedback and wider skill gaps [2:11:00];
    • The benefits of “backcasting” (and doing pre-mortems) [2:13:30];
    • Parting advice from Annie for those feeling overwhelmed (and two book recommendations) [2:21:30]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enSeptember 02, 2024

    #315 ‒ Life after near-death: a new perspective on living, dying, and the afterlife | Sebastian Junger

    #315 ‒ Life after near-death: a new perspective on living, dying, and the afterlife | Sebastian Junger

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    Sebastian Junger is an award-winning journalist, bestselling author, and previous guest on The Drive. In this episode, Sebastian returns to discuss his latest book, In My Time of Dying: How I Came Face to Face with the Idea of an Afterlife. This episode delves into Sebastian's profound near-death experience and how it became the catalyst for his exploration of mortality, the afterlife, and the mysteries of the universe. They discuss the secular meaning of what it means to be sacred, the intersection of physics and philosophy, and how our beliefs shape our approach to life and death. He also shares how this experience has profoundly changed him, giving him a renewed perspective on life—one filled with awe, gratitude, deeper emotional awareness, and a more engaged approach to living.

    We discuss:

    • How Sebastian’s near-death experience shaped his thinking about mortality and gave him a reverence for life [3:00];
    • The aneurysm that led to Sebastian’s near-death experience [6:30];
    • Emergency room response, his subsequent reflections on the event, and the critical decisions made by the medical team [16:30];
    • Sebastian’s reaction to first learning he nearly died, and the extraordinary skill of the medical team that save his life [26:00];
    • Sebastian’s near-death experience [37:00];
    • The psychological impact of surviving against overwhelming odds [48:00];
    • Ignored warning signs: abdominal pain and a foreshadowing dream before the aneurysm rupture [54:30];
    • Sebastian's recovery, his exploration of near-death experiences, and the psychological turmoil he faced as he questioned the reality of his survival [58:15];
    • A transformative encounter with a nurse who encouraged Sebastian to view his near-death experience as sacred [1:03:30];
    • How Sebastian has changed: a journey toward emotional awareness and fully engaging with life [1:08:45];
    • The possibility of an afterlife, and how quantum mechanics challenges our understanding of existence [1:15:15];
    • Quantum paradoxes leading to philosophical questions about the nature of reality, existence after death, and whether complete knowledge could be destructive [1:26:00];
    • The sweet spot of uncertainty: exploring belief in God, post-death existence, and meaning in life [1:37:00];
    • The transformative power of experiencing life with awe and gratitude [1:53:00]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enAugust 26, 2024

    #314 ‒ Rethinking nutrition science: the evolving landscape of obesity treatment, GLP-1 agonists, protein, and the need for higher research standards | David Allison, Ph.D.

    #314 ‒ Rethinking nutrition science: the evolving landscape of obesity treatment, GLP-1 agonists, protein, and the need for higher research standards | David Allison, Ph.D.

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    David Allison, a leading expert in obesity and nutrition, quantitative genetics, clinical trials, and research methodology, returns to The Drive to explore the evolving landscape of nutrition science and obesity treatment. In this episode, David begins by discussing the intricate relationship between nutrition, obesity, and body composition, emphasizing the multifaceted impacts of food beyond mere calorie intake. David provides a critical analysis of the complexities in nutrition research and their practical implications for tackling obesity. He critiques historical public health policies, addresses the trust issues plaguing nutrition science, and underscores the need for a paradigm shift to more effectively combat obesity. The conversation also delves into the rise of GLP-1 receptor agonists like Ozempic and Mounjaro, exploring their ethical and practical considerations in obesity treatment. The episode concludes with an in-depth look at protein intake recommendations and highlights the significant research gaps that remain in the field.

    We discuss:

    • The complex relationship between nutrition, body weight, and body composition [2:30];
    • The slow progress in addressing obesity and public health despite substantial effort and investment [7:30];
    • The very limited success of public health initiatives in curbing obesity [17:15];
    • The evolving landscape of obesity research: public health initiatives and the impact of pharmacological success [26:30];
    • Rethinking obesity solutions: the need for a paradigm shift [32:45];
    • Understanding environmental triggers and embracing a balanced approach to addressing obesity that includes both pharmacological treatments and realistic lifestyle changes [41:45];
    • The need for higher standards in obesity research [51:45];
    • The rapid success of GLP-1 receptor agonists for weight loss: a discussion on the societal impact and controversy of their growing usage [1:02:15];
    • The ethical and practical considerations of obesity drugs: risks, benefits, and motivations for usage [1:11:30];
    • The use of GLP-1 agonists by athletes as performance enhancers [1:23:45];
    • Unanswered questions about protein intake and health [1:30:45];
    • Future research needed to understand basic questions around protein intake [1:45:00];
    • David’s weekly newsletter: “Obesity and Energetics Offerings” [1:50:45]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enAugust 19, 2024

    #313 - AMA #62: Protein’s impact on appetite and weight management, and uric acid's link to disease and how to manage levels

    #313 - AMA #62: Protein’s impact on appetite and weight management, and uric acid's link to disease and how to manage levels

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    In this “Ask Me Anything” (AMA) episode, Peter dives into two important health topics: uric acid and protein, examining them from unique perspectives. For uric acid, he explores its metabolic role and connection to various diseases, focusing on the potential causal link with cardiovascular disease. He also discusses factors influencing uric acid levels, such as diet, genetics, and lifestyle, providing practical tips for effective management. Shifting to protein, Peter delves into its role in appetite and weight management, the consequences of insufficient protein, and the “protein leverage hypothesis” linking protein deficiency to obesity. He covers optimal protein intake and its impact on energy expenditure, and he compares the satiety effects of solid versus liquid protein. Finally, Peter shares his strategy for incorporating protein into a comprehensive weight management plan.

    If you’re not a subscriber and are listening on a podcast player, you’ll only be able to hear a preview of the AMA. If you’re a subscriber, you can now listen to this full episode on your private RSS feed or our website at the AMA #62 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.

    We discuss:

    • Overview of episode topics (and an important discussion on fanny packs) [2:00];
    • Understanding uric acid: its role in metabolic processes, its association with gout and kidney stones, its impact on blood pressure, and more [6:00];
    • Non-modifiable factors that influence uric acid levels [11:00];
    • Modifiable factors that influence uric acid levels [14:15];
    • Association between high uric acid levels and cardiovascular disease [20:00];
    • Evidence suggesting a causal link between high uric acid levels and cardiovascular disease [24:00];
    • Inconclusive evidence about the cardiovascular benefits of lowering uric acid pharmacologically [28:15];
    • Exploring the potential risks of low uric acid levels in neurodegenerative diseases [37:00];
    • Managing uric acid levels: dietary interventions and pharmacological approaches [42:00];
    • The impact of protein on appetite and weight management [44:00];
    • The consequences of insufficient protein on eating behaviors and satiety [52:15];
    • The relationship between protein deficiency and obesity: exploring the “protein leverage hypothesis” [57:15];
    • The impact of protein intake on energy expenditure [1:02:15];
    • Determining optimal protein intake to avoid deficiency and support health [1:05:45];
    • The role of different amino acids and protein sources in promoting satiety [1:08:15];
    • Comparing the satiety effects of solid vs. liquid protein sources [1:10:30];
    • Peter’s framework for incorporating protein intake into a strategy for controlling body weight [1:12:00]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enAugust 12, 2024

    #312 - A masterclass in lactate: Its critical role as metabolic fuel, implications for diseases, and therapeutic potential from cancer to brain health and beyond | George A. Brooks, Ph.D.

    #312 - A masterclass in lactate: Its critical role as metabolic fuel, implications for diseases, and therapeutic potential from cancer to brain health and beyond | George A. Brooks, Ph.D.

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    George A. Brooks is a renowned professor of integrative biology at UC Berkeley. Known for his groundbreaking "lactate shuttle" theory proposed in the 1980s, George revolutionized our understanding of lactate as a crucial fuel source rather than just a byproduct of exercise. In this episode, George clarifies common misconceptions between lactate and lactic acid, delves into historical perspectives, and explains how lactate serves as a fuel for the brain and muscles. He explores the metabolic differences in exceptional athletes and how training impacts lactate flux and utilization. Furthermore, George reveals the significance of lactate in type 2 diabetes, cancer, and brain injuries, highlighting its therapeutic potential. This in-depth conversation discusses everything from the fundamentals of metabolism to the latest research on lactate's role in gene expression and therapeutic applications.

    We discuss:

    • Our historical understanding of lactate and muscle metabolism: early misconceptions and key discoveries [3:30];
    • Fundamentals of metabolism: how glucose is metabolized to produce ATP and fuel our bodies [16:15];
    • The critical role of lactate in energy production within muscles [24:00];
    • Lactate as a preferred fuel during high-energy demands: impact on fat oxidation, implications for type 2 diabetes, and more [30:45];
    • How the infusion of lactate could aid recovery from traumatic brain injuries (TBI) [43:00];
    • The effects of exercise-induced lactate [49:30];
    • Metabolic differences between highly-trained athletes and insulin-resistant individuals [52:00];
    • How training enhances lactate utilization and facilitates lactate shuttling between fast-twitch and slow-twitch muscle fibers [58:45];
    • The growing recognition of lactate and monocarboxylate transporters (MCT) [1:06:00];
    • The intricate pathways of lactate metabolism: isotope tracer studies, how exceptional athletes are able to utilize more lactate, and more [1:09:00];
    • The role of lactate in cancer [1:23:15];
    • The role of lactate in the pathophysiology of various diseases, and how exercise could mitigate lactate's carcinogenic effects and support brain health [1:29:45];
    • George’s current research interests involving lactate [1:37:00];
    • Questions that remain about lactate: role in gene expression, therapeutic potential, difference between endogenous and exogenous lactate, and more [1:50:45]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enAugust 05, 2024

    #311 ‒ Longevity 101: a foundational guide to Peter's frameworks for longevity, and understanding CVD, cancer, neurodegenerative disease, nutrition, exercise, sleep, and more

    #311 ‒ Longevity 101: a foundational guide to Peter's frameworks for longevity, and understanding CVD, cancer, neurodegenerative disease, nutrition, exercise, sleep, and more

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    In this special episode, Peter provides a comprehensive introduction to longevity, perfect for newcomers or those looking to refresh their knowledge. He lays out the foundational concepts of lifespan, healthspan, and the marginal decade. Additionally, Peter discusses the four main causes of death and their prevention, as well as detailing the five key strategies in his longevity toolkit to improve lifespan and healthspan. Detailed show notes provide links for deeper exploration of these topics, making it an ideal starting point for anyone interested in understanding and improving their longevity.

    We discuss:

    • Key points about starting exercise as an older adult [2:45];
    • Overview of episode topics and structure [1:45];
    • How Peter defines longevity [3:45];
    • Why healthspan is a crucial component of longevity [11:15];
    • The evolution of medicine from medicine 1.0 to 2.0, and the emergence of medicine 3.0 [15:30];
    • Overview of atherosclerotic diseases: the 3 pathways of ASCVD, preventative measures, and the impact of metabolic health [26:00];
    • Cancer: genetic and environmental factors, treatment options, and the importance of early and aggressive screening [33:15];
    • Neurodegenerative diseases: causes, prevention, and the role of genetics and metabolic health [39:30];
    • The spectrum of metabolic diseases [43:15];
    • Why it’s never too late to start thinking about longevity [44:15];
    • The 5 components of the longevity toolkit [46:30];
    • Peter’s framework for exercise—The Centenarian Decathlon [47:45];
    • Peter’s nutritional framework: energy balance, protein intake, and more [58:45];
    • Sleep: the vital role of sleep in longevity, and how to improve sleep habits [1:08:30];
    • Drugs and supplements: Peter’s framework for thinking about drugs and supplements as tools for enhancing longevity [1:13:30];
    • Why emotional health is a key component of longevity [1:17:00];
    • Advice for newcomers on where to start on their longevity journey [1:19:30]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enJuly 29, 2024

    #310 - The relationship between testosterone and prostate cancer, testosterone replacement therapy, and tools for predicting cancer aggressiveness and guiding therapy | Ted Schaeffer, M.D., Ph.D.

    #310 - The relationship between testosterone and prostate cancer, testosterone replacement therapy, and tools for predicting cancer aggressiveness and guiding therapy | Ted Schaeffer, M.D., Ph.D.

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    Ted Schaeffer is an internationally recognized urologist specializing in prostate cancer and a returning guest on The Drive. In this episode, Ted provides insights into the role testosterone plays, or doesn't play, in the initiation and progression of prostate cancer. He unpacks the findings and limitations of the recent TRAVERSE trial, exploring the complex relationship between testosterone and prostate cancer. Ted delves into the molecular nature of prostate cancer, explaining the androgen receptor saturation theory and the potential impact of testosterone on cancer growth. He also discusses the use of the Decipher test to predict cancer aggressiveness and guide targeted treatment. Furthermore, Ted shares how he counsels patients regarding testosterone replacement therapy (TRT), including its safe administration in patients with low-grade prostate cancer. Additionally, he highlights advancements in prostate cancer therapies and biomarkers that help develop precise treatment strategies while minimizing the need for broad androgen deprivation therapy.

    We discuss:

    • Background on the TRAVERSE trial: insights into exogenous testosterone and prostate cancer risk [3:00];
    • The androgen receptor saturation theory: how different organs respond to varying levels of testosterone [10:30];
    • The relationship between testosterone levels and prostate cancer aggressiveness: how aggressive prostate tumors have lower androgen receptor activity and rely on different growth mechanisms [16:15];
    • Using the Decipher score to assess prostate cancer aggressiveness and guide personalized treatment strategies [23:45];
    • Considerations for testosterone replacement therapy: how Ted counsels patients, how TRT can be safely administered in patients with low-grade prostate cancer, and more [31:15];
    • Advancements in prostate cancer therapies and PSA as a biomarker for precise treatment decisions, minimizing the need for broad androgen deprivation therapy [38:30]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enJuly 22, 2024

    #309 ‒ AI in medicine: its potential to revolutionize disease prediction, diagnosis, and outcomes, causes for concern in medicine and beyond, and more | Isaac Kohane, M.D., Ph.D.

    #309 ‒ AI in medicine: its potential to revolutionize disease prediction, diagnosis, and outcomes, causes for concern in medicine and beyond, and more | Isaac Kohane, M.D., Ph.D.

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    Isaac "Zak" Kohane, a pioneering physician-scientist and chair of the Department of Biomedical Informatics at Harvard Medical School, has authored numerous papers and influential books on artificial intelligence (AI), including The AI Revolution in Medicine: GPT-4 and Beyond. In this episode, Zak explores the evolution of AI, from its early iterations to the current third generation, illuminating how it is transforming medicine today and unlocking astonishing possibilities for the future. He shares insights from his unconventional journey and early interactions with GPT-4, highlighting significant AI advancements in image-based medical specialties, early disease diagnosis, and the potential for autonomous robotic surgery. He also delves into the ethical concerns and regulatory challenges of AI, its potential to augment clinicians, and the broader implications of AI achieving human-like creativity and expertise.

    We discuss:

    • Zak’s unconventional journey to becoming a pioneering physician-scientist, and his early interactions with GPT-4 [2:15];
    • The evolution of AI from the earliest versions to today’s neural networks, and the shifting definitions of intelligence over time [8:00];
    • How vast data sets, advanced neural networks, and powerful GPU technology have driven AI from its early limitations to achieving remarkable successes in medicine and other fields [19:00];
    • An AI breakthrough in medicine: the ability to accurately recognize retinopathy [29:00];
    • Third generation AI: how improvements in natural language processing significantly advanced AI capabilities [32:00];
    • AI concerns and regulation: misuse by individuals, military applications, displacement of jobs, and potential existential concerns [37:30];
    • How AI is enhancing image-based medical specialties like radiology [49:15];
    • The use of AI by patients and doctors [55:45];
    • The potential for AI to augment clinicians and address physician shortages [1:02:45];
    • The potential for AI to revolutionize early diagnosis and prediction of diseases: Alzheimer’s disease, CVD, autism, and more [1:08:00];
    • The future of AI in healthcare: integration of patient data, improved diagnostics, and the challenges of data accessibility and regulatory compliance [1:17:00];
    • The future of autonomous robotic surgery [1:25:00];
    • AI and the future of mental health care [1:31:30];
    • How AI may transform and disrupt the medical industry: new business models and potential resistance from established medical institutions [1:34:45];
    • Potential positive and negative impacts of AI outside of medicine over the next decade [1:38:30];
    • The implications of AI achieving a level of creativity and expertise comparable to exceptional human talents [1:42:00];
    • Digital immortality and legacy: the potential to emulate an individual's personality and responses and the ethical questions surrounding it [1:45:45];
    • Parting thoughts [1:50:15]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enJuly 15, 2024

    Zone 2 training: impact on longevity and mitochondrial function, how to dose frequency and duration, and more | Iñigo San-Millán, Ph.D. (#201 rebroadcast)

    Zone 2 training: impact on longevity and mitochondrial function, how to dose frequency and duration, and more | Iñigo San-Millán, Ph.D. (#201 rebroadcast)

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    Iñigo San-Millán is an internationally renowned applied physiologist and a previous guest on The Drive. His research and clinical work focuses on exercise-related metabolism, metabolic health, diabetes, cancer metabolism, nutrition, sports performance, and critical care. In this episode, Iñigo describes how his work with Tour de France winner Tadej Pogačar has provided insights into the amazing potential of elite athletes from a performance and metabolic perspective. He speaks specifically about lactate levels, fat oxidation, how carbohydrates in food can affect our lactate and how equal lactate outputs between an athlete and a metabolically unhealthy individual can mean different things. Next, he discusses how Zone 2 training boosts mitochondrial function and impacts longevity. He explains the different metrics for assessing one’s Zone 2 threshold and describes the optimal dose, frequency, duration, and type of exercise for Zone 2. Additionally, he offers his thoughts on how to incorporate high intensity training (Zone 5) to optimize health, as well as the potential of metformin and NAD to boost mitochondrial health. Finally, he discusses insights he’s gathered from studying the mitochondria of long COVID patients in the ICU.

    We discuss:

    • The amazing potential of cyclist Tadej Pogačar [2:00];
    • Metrics for assessing athletic performance in cyclists and how that impacts race strategy [7:30];
    • The impact of performance-enhancing drugs and the potential for transparency into athletes’ data during competition [16:15];
    • Tadej Pogačar’s race strategy and mindset at the Tour de France [23:15];
    • Defining Zone 2, fat oxidation, and how they are measured [26:00];
    • Using fat and carbohydrate utilization to calculate the mitochondrial function and metabolic flexibility [35:00];
    • Lactate levels and fat oxidation as it relates to Zone 2 exercise [39:15];
    • How moderately active individuals should train to improve metabolic function and maximize mitochondrial performance [51:00];
    • Bioenergetics of the cell and what is different in elite athletes [56:30];
    • How the level of carbohydrate in the diet and ketogenic diets affects fuel utilization and power output during exercise [1:07:45];
    • Glutamine as a source for making glycogen—insights from studying the altered metabolism of ICU patients [1:14:15];
    • How exercise mobilizes glucose transporters—an important factor in diabetic patients [1:20:15];
    • Metrics for finding Zone 2 threshold—lactate, heart rate, and more [1:24:00];
    • Optimal Zone 2 training: dose, frequency, duration, and type of exercise [1:40:30];
    • How to incorporate high intensity training (Zone 5) to increase VO2 max and optimize fitness [1:50:30];
    • Compounding benefits of Zone 2 exercise and how we can improve metabolic health into old age [2:01:00];
    • The effects of metformin, NAD, and supplements on mitochondrial function [2:04:30];
    • The role of lactate and exercise in cancer [2:12:45];
    • How assessing metabolic parameters in long COVID patients provides insights into this disease [2:18:30];
    • The advantages of using cellular surrogates of metabolism instead of VO2 max for prescribing exercise [2:25:00];
    • Metabolomics reveals how cellular metabolism is altered in sedentary individuals [2:33:00];
    • Cellular changes in the metabolism of people with diabetes and metabolic syndrome [2:38:30]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enJuly 08, 2024

    #308 - AMA #61: Sun exposure, sunscreen, and skin health: relationship between sun exposure and skin cancer, vitamin D production, and photoaging, how to choose a sunscreen, and more

    #308 - AMA #61: Sun exposure, sunscreen, and skin health: relationship between sun exposure and skin cancer, vitamin D production, and photoaging, how to choose a sunscreen, and more

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    In this “Ask Me Anything” (AMA) episode, Peter delves into two topics that have generated a lot of questions over the years: skin cancer and sunscreen. He begins by exploring the basics of UV radiation, discussing its effects on vitamin D conversion, photoaging, and its role in skin cancer. He examines various skin types, discussing their implications for sun exposure and vitamin D levels, as well as how to determine where you fall on the skin type scale. He then delves into the various types of skin cancer, with a particular emphasis on melanoma, exploring its complex relationship with UV exposure and other contributing risk factors. Additionally, he covers tanning beds, the importance of early skin cancer detection through regular skin checks, and the often confusing topic of sunscreen. He explains how sunscreen affects UV radiation and skin cancer risk, what SPF levels to choose, the differences between organic and mineral sunscreens, and what to consider when selecting the best sunscreen for your needs.

    If you’re not a subscriber and are listening on a podcast player, you’ll only be able to hear a preview of the AMA. If you’re a subscriber, you can now listen to this full episode on your private RSS feed or our website at the AMA #61 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.

    We discuss:

    • The impact of UV radiation on the skin [2:00];
    • Understanding solar UV: from the electromagnetic spectrum to skin health [3:45];
    • The role of sunlight in vitamin D production [8:30];
    • Factors contributing to vitamin D deficiency: insufficient UV exposure, magnesium levels, and more [9:45];
    • Sun exposure needs for different skin types, and the limitations of current studies in defining vitamin D deficiency [12:45];
    • The acute and long-term effects of excessive UV exposure: sunburn, photoaging, and the increased risk of skin cancer [15:30];
    • Types of skin cancer and associations with UV exposure [17:45];
    • The complex relationship between melanoma and UV exposure [22:15];
    • Why UV exposure alone doesn’t necessarily explain the risk for melanoma [25:15];
    • Other risk factors for melanoma [29:15];
    • Tanning beds and skin cancer risk [34:45];
    • Balancing sun exposure: benefits and risks [38:15];
    • Tattoos and sun exposure [40:30];
    • The importance of regular skin checks, dermatologists, and emerging technologies showing promise for early detection of cancer [41:45];
    • Self-skin checks: what to look for [46:30];
    • Prevalence of skin cancer and the importance of early detection [49:30];
    • Summary of the major risk factors for melanoma [54:15];
    • The role of sunscreen in reducing skin cancer risk [55:45];
    • How sunscreen works, the differences between chemical and mineral sunscreens, an explanation of SPF, and more [58:30];
    • How to determine the appropriate sunscreen SPF to use based on the UV index [1:04:45];
    • Choosing the right sunscreen for your individual needs [1:07:00];
    • The impact of water and perspiration on sunscreen effectiveness [1:12:00];
    • Chemical vs. mineral sunscreens: safety concerns and recommendations [1:14:00];
    • Concerns about hormone effects from chemical sunscreens [1:19:15];
    • Sunscreen summary: skin types, key considerations, recommended brands, and more [1:23:15]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enJuly 01, 2024

    Related Episodes

    Ep. 30: The False Choice: Move Fast or Think Deeply

    Ep. 30: The False Choice: Move Fast or Think Deeply

    There is a false dichotomy between thinking deeply and moving fast. We are often presented with these as mutually exclusive choices and both have real advantages. But there is a way to do both at the same time--and it is a life changing insight (at least, it was for me).


    ---


    Sign up to have Scott email you a weekly shot of energy, with 1 Cool Quote, 1 Deep Thought, and 1 Useful Tool. This is original content, not a repost of the podcast. You can find the sign-up section at the bottom of my website www.ScottWozniak.com 


    Learn how Scott and his team of consultants can help you build a legendary brand at www.SwozConsulting.com 


    Connect with Scott on social media:  

    linkedin.com/in/scottwozniak/

    https://www.facebook.com/scottewozniak 


    ------  


    Bonus: check out his other podcast (Alpha Pack): https://kite.link/alpha-pack-podcast 

    If you like this podcast you will probably like that one, too. Who knows, you might even like it better! :)     

    Pizza, Ot ve Sting: İnternetten Alışverişin Kısa Tarihi

    Pizza, Ot ve Sting: İnternetten Alışverişin Kısa Tarihi

    Selam fularsızlar. Seçim var yarın ama hepimizin kafa kazan gibi olduğu için, söz verdiğim üzere alakasız bir içerikle karşınızdayım: İnternet üzerinden alışveriş tarihinin başlangıcını ve ilginç bazı tekrarlarını göreceğiz, mesela eve teslimat geleneğinin önce yok olup sonra teknolojiyle geri gelmesini göreceğiz. Arada bir Hindistan'a da uğrayıp çıkacağız. Kolay gelsin.


    Konular:

    • (00:20) İnternet üstünden satılan ilk şey.
    • (04:55) Cyber Monday.
    • (06:12) Dabbawala.
    • (10:05) İlk süpermarket.
    • (12:45) Devrimci İngiliz teyze.
    • (16:05) "30 dk veya bedava".
    • (17:30) Zamanının ötesindeki online marketler.
    • (20:38) Pandemi ve alışkanlıkların kırılması.


    Kaynaklar:


    ------- Podbee Sunar -------

    Bu podcast, Samsung hakkında reklam içerir.

    Samsung Galaxy S24/S24+ ve Galaxy S24 Ultra hakkında daha detaylı bilgi için tıklayınız.

    Bu podcast, Salus hakkında reklam içerir.

    Salus hakkında detaylı bilgi almak ve BASLANGIC10 koduyla %10 indirimden faydalanmak için tıklayınız.

    See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

    Launching an NIH Funded Study with Dr. Manish Shah

    Launching an NIH Funded Study with Dr. Manish Shah

    In the fiscal year 2021, the National Institute of Health (NIH) funded only 16,959 out of 80,878 research project grants. 

    In other words, the success rate was 21%.

    And the total funding amount was $8,827,444,624.

    The question I had was, “What does it take to get grant approval and launch an NIH funded research project?”

    To answer this question, I invited Dr. Manish Shah,  Professor of Pediatrics at Baylor College of Medicine and Attending Physician in the Texas Children’s Hospital Emergency Center in Houston. 

    Dr. Shah has served on several national committees to advocate for improvements in pediatric and prehospital emergency care. 

    His research has focused on developing, implementing, and studying outcomes related to evidence-based protocols for various clinical conditions, including seizures. 

    Dr. Shah is currently the Principal Investigator for the Pediatric Dose Optimization for Seizures in Emergency Medical Services (PediDOSE) study, which has been funded by the National Institute of Neurological Disorders and Stroke (NINDS) and is being conducted in the Pediatric Emergency Care Applied Research Network (PECARN).

    Please join me in welcoming Dr. Shah on the Clinical Trial Podcast. 

    This episode is brought you by Florence Healthcare. To learn more, please visit https://florencehc.com/

    Ep. 225 - Outrageous Miscarriage Of Justice In The Smollett Case

    Ep. 225 - Outrageous Miscarriage Of Justice In The Smollett Case

    Today on the Matt Walsh Show, in an outrageous development, Jussie Smollett, who staged a fake hate crime against himself, has been let go. All charges dropped. We will discuss this incredible miscarriage of justice. Also, the president of CNN makes a stunning admission, and a video of Pope Francis that you have to see to believe.  03-26-2019

    Learn more about your ad choices. Visit podcastchoices.com/adchoices